Mr. Shayne Laidlaw reports

CRONOS GROUP INC. ANNOUNCES RESULTS OF 2022 ANNUAL MEETING OF SHAREHOLDERS

At Cronos Group Inc.'s annual meeting of shareholders held on June 23, 2022, shareholders voting in person or by proxy held in total 265,763,587 common shares of the company, representing 70.76 per cent of the total number of common shares of the company outstanding.

Each of the directors listed as a nominee in the company's proxy statement dated April 29, 2022, was elected as a director of the company, with each director receiving in excess of 91.6 per cent of the votes cast in favour of his or her election. The detailed results of the vote for the election of directors are as shown in the attached table.

Shareholders also approved an advisory (non-binding) resolution on the compensation of the company's named executive officers, with 95.02 per cent of votes cast in favour of such resolution, and approved the reappointment of KPMG LLP as the company's independent auditor.

For complete results on all matters voted on at the meeting, please see the report of voting results filed on the company's SEDAR profile on SEDAR and the company's Form 8-K filed on EDGAR.

About Cronos Group Inc.

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos's diverse international brand portfolio includes Spinach, Peace Naturals, Lord Jones, Happy Dance and Peace+.

We seek Safe Harbor.